Increased per cell IFN-γ productivity indicates recent in vivo activation of T cells

Cellular Immunology

Volumn 258, Issue 2, 2009, Pages 131-137

  Schlingmann, Tobias R ^a   Shive, Carey L ^b   Targoni, Oleg S ^b   Tary Lehmann, Magdalena ^a,b   Lehmann, Paul V ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Cellular Technology Limited   (United States)

Author keywords

Cytokine productivity; ELISPOT; Interferon gamma; T cell memory; Vaccinia

Indexed keywords

GAMMA INTERFERON; SMALLPOX VACCINE; VACCINIA VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNITY; IMMUNIZATION; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REVACCINATION; SINGLE DRUG DOSE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; CYTOKINES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; MALE; MIDDLE AGED; SMALLPOX VACCINE; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; VACCINES, SUBUNIT; VACCINIA VIRUS;

VACCINIA VIRUS;

EID: 67649344110     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.04.002     Document Type: Article

References (33)

1. + T cells during an acute virus infection. Immunity 8 (1998) 167-175
2. + T cells. Science 280 (1998) 227
3. Perfetto S.P., Chattopadhyay P.K., and Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4 (2004) 648-655
4. + T cells. Blood 107 (2006) 4781-4789
5. Darrah P.A., Patel D.T., De Luca P.M., Lindsay R.W., Davey D.F., Flynn B.J., Hoff S.T., Andersen P., Reed S.G., Morris S.L., Roederer M., and Seder R.A. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13 (2007) 843-850
6. Kannanganat S., Ibegbu C., Chennareddi L., Robinson H.L., and Amara R.R. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J. Virol. 81 (2007) 8468-8476
7. Precopio M.L., Betts M.R., Parrino J., Price D.A., Gostick E., Ambrozak D.R., Asher T.E., Douek D.C., Harari A., Pantaleo G., Bailer R., Graham B.S., Roederer M., and Koup R.A. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 204 (2007) 1405-1416
8. + T lymphocytes with cellular maturation. J. Exp. Med. 203 (2006) 2865-2877
9. Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., and Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol. Rev. 211 (2006) 236-254
10. Makedonas G., and Betts M.R. Polyfunctional analysis of human T cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin. Immunopathol. 28 (2006) 209-219
11. Pantaleo G., and Harari A. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 6 (2006) 417-423
12. Combadiere B., Boissonnas A., Carcelain G., Lefranc E., Samri A., Bricaire F., Debre P., and Autran B. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J. Exp. Med. 199 (2004) 1585-1593
13. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., and Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171 (2003) 4969-4973
14. Demkowicz W.E., Littaua R.A., Wang J., and Ennis F.A. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 70 (1996) 2627-2631
15. Frey S.E., Newman F.K., Yan L., Lottenbach K.R., and Belshe R.B. Response to smallpox vaccine in persons immunized in the distant past. JAMA 289 (2003) 3295-3299
16. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., Hanifin J.M., and Slifka M.K. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9 (2003) 1131-1137
17. Chaudhri G., Panchanathan V., Bluethmann H., and Karupiah G. Obligatory requirement for antibody in recovery from a primary poxvirus infection. J. Virol. 80 (2006) 6339-6344
18. + T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol. 175 (2005) 6829-6836
19. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70 (1996) 8301-8309
20. Xu R., Johnson A.J., Liggitt D., and Bevan M.J. Cellular and humoral immunity against vaccinia virus infection of mice. J. Immunol. 172 (2004) 6265-6271
21. Dong Y., and Denny T.N. HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses. J. Infect. Dis. 194 (2006) 168-175
22. Drexler I., Staib C., Kastenmuller W., Stevanovic S., Schmidt B., Lemonnier F., Rammensee H.G., Busch D.H., Bernhard H., Erfle V., and Sutter G. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc. Natl. Acad. Sci. USA 100 (2003) 217-222
23. Oseroff C., Kos F., Bui H.H., Peters B., Pasquetto V., Glenn J., Palmore T., Sidney J., Tscharke D.C., Bennink J.R., Southwood S., Grey H.M., Yewdell J.W., and Sette A. HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc. Natl. Acad. Sci. USA 102 (2005) 13980-13985
24. + T-cell peptide epitope of vaccinia and variola viruses. J. Virol. 78 (2004) 7052-7060
25. Terajima M., Cruz J., Raines G., Kilpatrick E.D., Kennedy J.S., Rothman A.L., and Ennis F.A. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J. Exp. Med. 197 (2003) 927-932
26. Openshaw P., Murphy E.E., Hosken N.A., Maino V., Davis K., Murphy K., and O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182 (1995) 1357-1367
27. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J., Zajac A.J., Miller J.D., Slansky J., and Ahmed R. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8 (1998) 177-187
28. Helms T., Boehm B.O., Asaad R.J., Trezza R.P., Lehmann P.V., and Tary-Lehmann M. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J. Immunol. 164 (2000) 3723-3732
29. Hofstetter H.H., Targoni O.S., Karulin A.Y., Forsthuber T.G., Tary-Lehmann M., and Lehmann P.V. Does the frequency and avidity spectrum of the neuroantigen-specific T cells in the blood mirror the autoimmune process in the central nervous system of mice undergoing experimental allergic encephalomyelitis?. J. Immunol. 174 (2005) 4598-4605
30. Guerkov R.E., Targoni O.S., Kreher C.R., Boehm B.O., Herrera M.T., Tary-Lehmann M., Lehmann P.V., and Schwander S.K. Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J. Immunol. Methods 279 (2003) 111-121
31. Hesse M.D., Karulin A.Y., Boehm B.O., Lehmann P.V., and Tary-Lehmann M. A T cell clone's avidity is a function of its activation state. J. Immunol. 167 (2001) 1353-1361
32. Ott P.A., Tary-Lehmann M., and Lehmann P.V. The secretory IFN-gamma response of single CD4 memory cells after activation on different antigen presenting cell types. Clin. Immunol. 124 (2007) 267-276
33. Williams M.A., and Bevan M.J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25 (2007) 171-192